Skip to content

Insider · CIK 0001601264

Dybbs Michael

Reports to the SEC for 6 companies · SOUTH SAN FRANCISCO, CA

Transactions

28

Companies

6

Filings

20

CIK

0001601264

Forms 4 and 5

Insider transactions

28 trades
DateCompanyValue
2026-06-10NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2026-06-05STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2026-06-03KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2026-02-05SGPSpyGlass Pharma, Inc. · Stock Option (right to buy)A Award—
2025-12-23STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2025-06-06STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2025-06-05NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2025-04-10KLRSKalaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2024-06-13NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2024-06-06STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2023-06-08STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2023-06-07NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2022-06-08NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2022-06-06STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2021-06-13NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2021-06-03STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2020-07-09NKTXNkarta, Inc. · Stock Option (right to buy)A Award—
2020-06-05STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy)A Award—
2019-06-17STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy Common Stock)A Award—
2018-09-26STROSUTRO BIOPHARMA, INC. · Stock Option (right to buy Common Stock)A Award—
2017-11-07Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2017-11-07Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer—
2017-05-25Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2016-05-19Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award—
2015-10-27Dimension Therapeutics, Inc.C Conversion—
2015-10-27Dimension Therapeutics, Inc.P Purchase+$12.5M
2015-10-27Dimension Therapeutics, Inc.Series B Preferred StockC Conversion—
2014-03-20Aravive, Inc.Stock Option (Right to Buy)A Award—

Recent filings

20